Contact
Home • Our expertise • Medical & Scientific Affairs

Medical & Scientific Affairs.

Elevate the impact of your medical and scientific innovation.

Get in touch with a Medical & Scientific Affairs expert

What we do.

We provide world-class thought partnership and solutions that enhance the business impact of medical and scientific affairs. Centered on deep vertical expertise paired with a pioneering ethos and large-scale data capabilities, we support teams across a wide range of needs including asset development, launch strategy, and digital health and omnichannel strategy.

How we help.

Get credible industry knowledge and medical affairs strategic expertise across a wide range of therapeutic areas, rare diseases, biologics, vaccines, and cell and gene therapies.

Learn about our Centers of Excellence

We can help you solve challenges in asset development, launch strategy, digital health, and omnichannel strategy through:

  • Development strategy (i.e., indication and endpoint prioritization)
  • Scientific narrative
  • Integrated medical evidence
  • Launch planning
  • Stakeholder engagement
  • Center of excellence profiling and best practices
  • Organizational structure and benchmarking
  • AI landscape assessments
  • Digital therapeutics strategy and planning
  • Omnichannel strategy and metrics

Our offerings.

Tap to view Asset Development

Asset Development

Asset Development
Tap to view Launch Strategy

Launch Strategy

Launch Strategy
Tap to view Digital Health & Omnichannel Strategy

Digital Health & Omnichannel Strategy

Digital Health & Omnichannel Strategy

Case studies in related areas.

See how we’re helping clients solve key challenges and deliver on their amibitions

More insights

Local medical launch readiness plans

Putnam helped the client to support development of local medical launch readiness plans for a new vaccine.

Read more

AI algorithm landscape assessment

Read how our client aims to locate organizations advancing AI algorithms for rare disease detection.

Read more

Asset medical lifecycle plan

US and EU regulatory agencies provided the client with new guidance on generating supportive evidence for the proposed launch indication and future.

Read more

Our Medical Scientific Affairs Lead.

Lori Klein, PharmD

Partner, Medical and Scientific Affairs Practice Lead

Read bio

About Lori.

Lori leads the Medical and Scientific Affairs Practice at Putnam. Her expertise includes multi-stakeholder engagement, Center of Excellence profiling, organizational design, strategic medical launches, integrated medical evidence ideation, omnichannel strategy, and digital health platforms, including digital therapeutics, AI algorithms, and software as a medical device. Lori has experience in rare diseases including Duchenne muscular dystrophy, hemophilia, growth hormone deficiency, cardiac amyloidosis, acromegaly, sickle cell disease, and primary hyperoxaluria as well as oncology, infectious disease,
cardiology, critical care, neurology, and endocrinology.

Latest thinking.

Get the latest insights and perspectives from our experts.

View all of our resources

Leading world-class Medical Affairs into the future: Insights from Putnam’s Medical Affairs Leadership Council (Spring 2024)

We recently reconvened our Medical Affairs Leadership Council, discussing top of mind topics with leaders.

Read more

Learnings from MAPS Americas 2024

Putnam experts share key learnings coming out of MAPS Americas 2024

Read more

CNS indication/ Endpoint prioritization

A biopharma client with an early clinical stage compound, showing efficacy across multiple neuropsychiatric conditions, wished to prioritize...

Read more

Medical Affairs omnichannel platform

A large biopharma client objective aimed to optimize its omnichannel (OC) approach for HCP and patient Medical Education...

Read more

Get in touch.

Looking to get in touch with an expert or team member?

Tell us how we can help.

Contact us today